Nergis Akay

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Tuberculosis Diagnosis and Prevention in Children on Biological Treatment: Clinical Challenges and Considerations.

Tuberculosis Diagnosis and Prevention in Children on Biological Treatment: Clinical Challenges and Considerations.

Journal: Turkish archives of pediatrics

Published: July 02, 2026

Neurological Complications in Pediatric Takayasu Arteritis: Insights from a Single-Center Experience.

Neurological Complications in Pediatric Takayasu Arteritis: Insights from a Single-Center Experience.

Journal: Journal of clinical medicine

Published: June 06, 2026

Kikuchi-Fujimoto Disease: A Rare Cause of Lymphadenopathy and Prolonged Fever.

Kikuchi-Fujimoto Disease: A Rare Cause of Lymphadenopathy and Prolonged Fever.

Journal: Turkish archives of pediatrics

Published: June 02, 2026

Predictors of severe coronary involvement in children with Kawasaki disease: a single-centre cohort study.

Predictors of severe coronary involvement in children with Kawasaki disease: a single-centre cohort study.

Journal: Cardiology in the young

Published: June 01, 2026

Juvenile Localized Scleroderma with Cutaneous and Extracutaneous Involvement: Long-Term Observational Outcomes from a Referral Center.

Juvenile Localized Scleroderma with Cutaneous and Extracutaneous Involvement: Long-Term Observational Outcomes from a Referral Center.

Journal: Turkish archives of pediatrics

Published: April 27, 2026

Canakinumab dosing intervals in pediatric colchicine-resistant FMF: outcomes and predictors of successful extension in a real-world cohort.

Canakinumab dosing intervals in pediatric colchicine-resistant FMF: outcomes and predictors of successful extension in a real-world cohort.

Journal: Rheumatology (Oxford, England)

Published: April 08, 2026

Association between canakinumab dose and long-term remission in Still's disease: insights from the AIDA network registry.

Association between canakinumab dose and long-term remission in Still's disease: insights from the AIDA network registry.

Journal: Frontiers in pharmacology

Published: April 03, 2026

Biologic and targeted synthetic therapies in juvenile idiopathic arthritis: a review of current and emerging therapeutic agents.

Biologic and targeted synthetic therapies in juvenile idiopathic arthritis: a review of current and emerging therapeutic agents.

Journal: Expert opinion on drug safety

Published: March 03, 2026

Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study.

Tumor necrosis factor inhibitor-related autoimmune disorders in pediatric rheumatology practice: a multicenter nationwide study.

Journal: Pediatric rheumatology online journal

Published: March 02, 2026

Infection-Triggered Presumed Isolated Necrotizing Digital Vasculitis Presenting as Systemic Vasculitis.

Infection-Triggered Presumed Isolated Necrotizing Digital Vasculitis Presenting as Systemic Vasculitis.

Journal: Balkan medical journal

Published: February 24, 2026

Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.

Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.

Journal: Seminars in arthritis and rheumatism

Published: February 24, 2026

Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network.

Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network.

Journal: Rheumatology (Oxford, England)

Published: February 10, 2026

Showing 1-12 of 35

Last Updated: 09/26/2026